Login to get immediate access to this content.
LoginSpeaker: Kohei Shitara, Japan
Abstract discussed:
- LBA3 - Final analysis of the phase 3 KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal junction cancer - Watch the session from ESMO Gastrointestinal Cancers Congress 2024 now
The study results covered, and speakers in this video series, have been selected exclusively by ESMO.
Published July 2024